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Sida acuta is a shrub indigenous to pantropical regions. The plant is widely used for its various 
pharmacological properties. Among compounds of pharmacological interest occurring in the plant, are 
indoloquinoline alkaloids. The aim of the present study was to investigate the antimicrobial activity of 
alkaloids of S. acuta from Burkina Faso. The alkaloids had a good antimicrobial activity against the test 
microorganisms. In the agar-well diffusion assay, highest inhibition zone diameters were recorded with 
Gram-positive bacteria. The broth microdilution assay gave minimal inhibitory concentration values 
ranging from 16 to 400 µg/ml and minimal bactericidal concentration values ranging from 80 to up to 400 
µg/ml. The gas chromatography-mass spectrometry analysis of the same alkaloids led to the 
identification of cryptolepine and quindoline as the major components.  
 





Using plants for medicinal purposes is an important part 
of the culture and the tradition in Africa. Thus, up to 80% 
of the population depend directly on the traditional 
medicine for the primarily health care (Kirby, 1996). This 
traditional medicine uses numerous plants, among them, 
Sida Acuta Burm f. (Malvaceae). S. Acuta is a shrub 
indigenous to pantropical areas, widely distributed in 
these regions and widely used in traditional medicine. The 
aerial part of the plant is the most frequently used part. In 
central America, the plant is used to treat asthma, renal 
inflammation, colds, fever, headache, ulcers and worms 
(Caceres et al., 1987; Coee and Anderson, 1996). In 
Colombia the plant is known to treat snake bites. Otero et 
al. (2000 a,b) demonstrated that the ethanolic extract of 
the plant had an effective moderate activity against the 
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Burkina Faso, S. acuta often called “arbre à balai” in 
French and “zon-raaga” in Mooré, an indigenous 
language, grows around habitations in farms and in 
bushes. The plant is traditionally used in the treatment of 
malaria, diarrhoea and many other diseases 
(Nacoulma/ouedraogo, 1966). Research focussed on 
malaria led to the identification of alkaloids, principally 
cryptolepine the major alkaloid of the plant, as its 
antimalarial agent (Banzouzi et al., 2004; Karou et al., 
2003). More recently, we found that polyphenol extract of 
the plant had a weak antioxidant activity through in vitro 
free radicals scavenging assays, on the other hand the 
extract was very active on pathogenic bacteria and this 
activity may be influenced by the polymerisation size of 
the phenolic compounds (Karou et al., 2005). 
Phytochemical screening on S. acuta resulted in the 
isolation of several alkaloids and steroidal compounds 
with the potential to induce quinone reductase and to 
inhibit 7,12-dimethylbenz-(a) anthacene induced preneo-
plastic lesions in mouse mammary organ (Cao and Qi, 






Among the compounds isolated from S. acuta, its 
alkaloids appeared to be of great interest in 
pharmacological studies. These alkaloids belong to the 
family of indoloquinolines. Many investigations have been 
done on this family of compounds and the results showed 
that they are new leads in the establishment of drugs 
against many diseases. For example, cryptolepine 5-
méthylindolo (2-3b)-quinoline, the main alkaloid of the 
plant, has been well investigated for its various biological 
properties. First isolated from Cryptolepis species (C. 
triangularis and C. sanguinolenta (Periplocaceae)) from 
Africa (Clinquart, 1929; Dwuma-Badu et al., 1978), the 
compound has been also isolated from other plants such 
as S. acuta (Malvaceae) from Sri Lanka (Gunatilaka et 
al., 1980), Microphilis guyanensis (Sapotaceae) and 
Genipa americana (Rubiaceae) from Surinam (Yang et 
al., 1999). In Ghana, extracts of roots of C. 
Sanguinolenta, in which cryptolepine is the main alkaloid, 
have been used clinically to treat malaria, colic and 
stomach ulcers (Boye and Ampofo, 1983). Cryptolepine 
itself is found to produce many pharmacological effects 
such as antimicrobial (Cimanga et al., 1998), 
antiprotozoal (Arzel et al., 2001; Wright et al., 2001), 
antihyperglycemic (Bierer et al., 1998) and cytotoxic 
effects through GC-rich DNA sequence intercalation that 
provides basis for design of new anticancer drug 
(Bonjean et al., 1998; Dassonneville et al., 2000; Guittat 
et al., 2003; Lisgarten et al., 2002). 
The purpose of the present study was to investigate the 
antimicrobial activity of alkaloids from S. acuta against 
Gram-positive and Gram-negative bacteria. The selected 
microorganisms included reference strains and fresh 
clinical strains isolated from pathologic products. We also 
performed the GC-MS analysis of the same alkaloid 




MATERIALS AND METHODS 
 
Plant material and alkaloids extraction 
 
Samples of the aerial part of S. acuta were collected in 
Ouagadougou in July 2003. The plant was botanically authenticated 
as previously indicated (Karou et al., 2003).The ground sample was 
made alkaline with 28% ammonia and extracted with chloroform at 
room temperature for a total period of 24 h and then the extract was 
partitioned between 5% HCl and chloroform. The aqueous phase 
was made alkaline again with ammonia and partitioned between 
water and chloroform. Finally chloroform was totally evaporated 





Gas chromatography-Mass Spectrometry (GC-MS) analysis was 
performed with an auto HRGC/MS Carlo Erba Instrument using a 
SPB 5 (30 m / 0.25 mm / 0.5 µm) capillary column. 6 µ of 1 mg/ml 
alkaloids dissolved in methanol was injected in the following 
conditions: injector temperature, 280°C; carrier gas, helium; 
pressure,  




150 kPa; ion voltage, 60 eV; temperature  gradient,  20°C per 
minute from 100 to 315°C. Compounds were identified on the basis 
of their mass spectral data. 
 
 
Microorganisms, antibiotics and media 
  
Commercially available antibiotics discs, penicillin 10 IU/IE/UI, 
sulfadiazin 0.25 mg and spectinomycin 100 µg were purchased 
from Beckton Dickinson. All media used were from Oxoid. 
Microorganisms included reference strains and fresh clinical 
isolates. The selection of clinical microorganisms depended on their 
availability, thus microorganisms that have been reported to be the 
most frequently implicated in infectious diseases in tropical areas 
were well represented (Bonfiglio et al., 2002). Clinical isolates were: 
Staphylococcus aureus (n = 11), Enterococcus faecalis (n = 3), 
Shigella boydii (n = 4), Shigella flexneri (n = 5) Shigella dysenteriae 
(n = 3), Salmonella thyphi (n = 3), Salmonella parathyphi B (n = 3) 
and Escherichia coli (n = 4). All these strains were isolated from 
clinical samples at Laboratoire de Biologie Médicale Saint Camille 
in Ouagadougou. The microorganisms were identified by the use of 
their biochemical profiles as recommended by the manual 
“Bactériologie Médicale” (Leminor and Veron, 1984). The reference 
strains were Staphylococcus aureus ATCC 25923, Staphylococcus 
aureus ATCC 53154, Staphylococcus carmonum LMG 13567, 
Bacillus cereus LMG 13569, Listeria innocua LMG 13568, 
Enterococcus faecalis CIP 103907, Shigella dysenteriae CIP 54051 





Agar-well diffusion: The assay was conducted as described by 
Perez et al. (1990). Briefly, microorganisms from growth on nutrient 
agar incubated at 37°C for 18 h were suspended in saline solution 
0.85% NaCl and adjusted to a turbidity of 0.5 Mac Farland 
standards (108 cfu/ml). The suspension was used to inoculate 90 
mm diameter Petri plates with a sterile non toxic cotton swab on a 
wooden applicator. Six millimeters diameter wells were punched in 
the agar and filled with 50 µl of 2000 µg/ml alkaloids. The 
dissolution of the alkaloids was aided by 1% (v/v) DMSO which did 
not affect microorganisms growth, according to our control 
experiments. Commercial antibiotics were used as positive 
reference standard to determine the sensitivity of the strains. Discs 
were directly placed onto the bacterial culture. Plates were 
incubated in air at 37°C for 24 h. Antibacterial activities were 
evaluated by measuring inhibition zone diameters. The experiments 
were conducted twice. 
 
Broth microdilution assay: Broth microdilution method was used 
to determine minimal inhibitory concentrations (MIC) and minimal 
bactericidal concentrations (MBC) of alkaloids against the test 
microorganisms as recommended by the National Committee for 
Clinical Laboratory Standards (NCCLS, 2002). The tests were 
performed in 96 well-plates. Alkaloids dissolved in 1% DMSO were 
transferred in plates to obtain a twofold serial dilutions ranging from 
3.2 to 400 µg/ml. Then plates were inoculated with microbial 
suspensions diluted from the same 0.5 Mac Farland standards to 
have 105 cfu/ml in each well. The final volumes in wells were 200 µl. 
After 24 h incubation in air at 37°C, MIC was recorded as a lowest 
extract concentration demonstrating no visible growth in the broth. 
MBC was recorded as a lowest extract concentration killing 99.9% 
of bacterial inocula. MBC values were determined by removing 100 
µl of bacterial suspension from subculture demonstrating no visible 
growth and inoculating nutrient agar plates. Plates were incubated 
at 37°C for a total period of 48 h.  
  






















Time-kill assay: Escherichia coli CIP 105182 and Shigella 
dysenteriae CIP 54051 were chosen arbitrary to perform time-kill 
assay.  Thus,   0.5   Mac   Farland   standards   suspensions   of   
the 
microorganisms were diluted to have 50 ml of approximately 105 
cfu/ml in nutrient broth, then 160 and 480 µg/ml alkaloids that 
corresponded to 2 MIC of Escherichia coli CIP 105182 and Shigella 
dysenteriae CIP 54051, respectively, were added to the 
corresponding culture. The cultures were incubated in air at 37°C in 
INNOVATM 4000 incubator shaker. At 0, 1, 2, 3, 4, 5 and 6 h, an 
aliquot of 100 µl was removed and diluted with 10 ml sterile broth. 
The obtained suspension was used to inoculate 90 mm diameter 
Petri plates with a sterile non toxic cotton swab on a wooden 
applicator as indicated before in the agar-well diffusion assay. After 
48 h incubation at 37°C, the viability of the microorganisms was 
evaluated by the presence of colonies on the plates. The 
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Figure 2. Chemical structure of identified compounds from the Sida 
acuta alkaloid extract 
 
 
RESULTS AND DISCUSSION 
 
Gas chromatogram as shown on Figure 1 yielded two 
major peaks (retention times (rt): 15.39 and 15.72) and 
two minor peaks (retention times: 12.83 and 14.95). The 
two major peaks (rt 15.39, MS (EI, m/z) 232 (100 %) and 
rt 15.72 MS (EI, m/z) 218 (100 %)) were identified as 
cryptolepine and quindoline, respectively (Figure 2), on 
the basis of their fragmentation data that were in 
agreement with reported values (Dwuma-Badu et al., 
1978; Paulo et al., 1995; Pousset et al., 1995). The two 
alkaloids have been found to occur in S. acuta and other 
species (Banzouzi et al., 2004; Gunatilaka et al., 1980).  
For the treatment of several infections in Africa, 
indigenous medicinal plants are often the only means 
(Fenell et al., 2004; Taylor et al., 2001). This highlights 
the continuous interest in laboratory screening of 
medicinal plants, not only to determine the scientific 
rationale for their usage, but also to discover new active 
principles. African medicinal plants have been screened 
for their in vitro antibacterial activities and many described 
antibacterial activities have been focussed on phenolic 
compounds, terpenoids or essential oils (Bassole et al., 
2003; Erasto et al., 2004; Viljoen et al., 2003). The plants 
have been found to exert good in vitro antimicrobial 
activities and some active principles have been isolated. 
Examples are muzigadial isolated from Warburgia 
salutaris (Bertol. f) Chiov.  (Canellaceae)  (Rabe and Van 
Staden, 2000) and Vernodalin from Vernonia colorata 
(Willd) Drake (Asteraceae) (Reid et al., 2001). Alkaloids 
have been well investigated for many pharmacological 
properties including antiprotozoal, cytotoxic, 
antiinflammatory properties but there are only few reports 
about their antimicrobial properties. The anti-bacterial 
assays in this study were performed by the agar-well 






Table 1. Inhibition zone diameters (mm) recorded in agar-well 




Pen Sulf Spec Alk 
S. aureus (n = 6) + nd nd 14±03 25±4 
S. aureus (n = 5) + 39±0
9 
nd 16±02 27±7 
S. aureus ATCC 
25923 
+ nd nd 20±00 28 
S. aureus ATCC 
53154 
+ nd nd 29 29 
S. carmonum LMG 
13567 
+ 40 nd 20 20 
B. cereus LMG 13569 + nd nd 29 20 
L. innocua LMG 13568 + 27 nd 20 29 
E. faecalis (n = 3) + 35±0
5 
nd 20±00 38±02 
E. faecalis CIP 
103907 
+ 30 nd 20 35 
Sh. boydii (n = 4) - nd nd 18±01 17±02 
Sh. flexneri (n = 5) - nd nd 20±05 18±7 
Sh. dysenteriae (n = 
3) 
- nd nd 21±02 18±00 
Sh. dysenteriae CIP 
54051 
- nd nd 18 18 
Sal. Thyphi (n = 3)  - nd nd 18±02 00 
Sal parathyphi B (n 
=3) 
- nd nd 20±01 00 
E. coli (n= 4) - nd nd 16±01 16±04 
E. coli CIP 105182. - nd nd 20 20 
 
Results are the means of diameters values ± standard deviations.  
Pen: penicillin (10 UI), Sulf : sulfadiazin (0.25 mg), Spec: spectinomycin 




Table 2. Means of MIC and MBC recorded in the microdilution 
assay using the Sida acuta alkaloid extract.  
 
Microorganism Gram MIC MBC 
S. aureus Pen- (n = 6) + 240±00 240±00 
S. aureus Pen+ (n = 5) + 80±00 80±00 
S. aureus ATCC 25923 + 400 >400 
S. aureus ATCC 53154 + 400 >400 
S. carmonum LMG 13567 + 80 240 
B. cereus LMG 13569 + 80 >400 
L. innocua LMG 13568 + 16 240 
E. faecalis (n = 3) + 16±00 >400 
E. faecalis CIP 103907 + 16 >400 
Sh. boydii (n = 4) - 80±00 240±00 
Sh. flexneri (n = 5) - 80±00 186±54 
Sh. dysenteriae (n = 3) - 400±00 240±00 
Sh. dysenteriae CIP 54051 - 400 240 
Sal. Thyphi (n = 3)  - np np 
Sal parathyphi B (n = 3) - np np 
E. coli (n= 4) - 80±00 240±00 
E. coli CIP 105182. - 80 80 
 
Results are the means of diameters values ± standard deviations.  
Pen-: for penicillin resistant S. aureus; Pen+: for penicillin susceptible 
S. aureus; np: no performed assay. 




they  could  be  qualified  and  quantified  by  inhibition 
zone diameters, MIC and MBC values as summarized in 
Tables 1 and 2. The susceptibility of the bacteria to the 
extract, on the basis of inhibition zone diameters varied 
according to microorganisms, but globally, the highest 
inhibition zone diameters were recorded with Gram-
positive bacteria (Table 1). Curiously, there was no 
inhibition with Salmonella species, thus these strains were 
not included in the micro dilution assay. 
The microdilution assay gave MIC values ranging from 
16 to 400 µg/ml and 80 to 400 µg/ml for MBC for different 
strains (Table 2). Great MBC values were obtained with 
Gram-positive bacteria, however, these results could not 
show  clearly  weather  Gram-positive  bacteria  or Gram-
negative ones were more susceptible to the extract, but it 
is evidence that the extract displayed either 
microbiostactic (MBC 2, 3 or more times greater than 
MIC) or microbicide (equal values of MIC and MBC) 
effects on the different strains. It is reported that Gram-
positive bacteria should be more susceptible since they 
have only an outer peptidoglycan layer which is not an 
effective barrier (Scherrer and Gerhardt, 1971). The 
Gram-negative bacteria have an outer phospholipidic 
membrane that make the cell wall impermeable to 
lipophilic solutes, while the porines constitute a selective 
barrier to hydrophilic solutes with an exclusion limit of 
about 600 Da (Nikaido and Vaara, 1985). Many results 
confirmed these observations, thus some plant extracts 
were found to be more active against Gram-positive 
bacteria than against Gram-negative ones (Kelmanson et 
al., 2000; Masika and Afolayane, 2002).  
Phytochemicals exert their antimicrobial activity through 
different mechanisms, tannins for example act by iron 
deprivation, hydrogen bounding or non specific 
interactions with vital proteins such as enzymes (Scalbert, 
1991). In the case of indoloquinoline alkaloids the 
mechanism remains unclear. Sawer et al. (2005) 
demonstrated that the main indoloquinoline alkaloid, 
cryptolepine, causes cell lysis and morphological changes 
of S. aureus, but the antimicrobial effects of the alkaloid 
may be through another mechanism, since the compound 
is known to be a DNA intercalator and an inhibitor of DNA 
synthesis through topoisomerase inhibition (Bonjean et 
al., 1998; Dassonneville et al., 2000; Guittat et al., 2003; 
Lisgarten et al., 2002). 
In order to follow the reduction of the amount of 
microorganisms in an inoculum as a function of the time, 
time-kill assay was performed with E.  coli CIP 105182 
and Sh.  dysenteriae CIP 54051, arbitrarily selected 
among the test microorganisms. The results showed that 
after 5 h exposition there was no viable microorganism in 
the initial inoculum (Table 3) and the effect of alkaloids 
was faster on E. coli than it was on Sh. dysenteriae. 
In conclusion, the alkaloids displayed good antimicro-
bial activity against several test microorganisms. The GC-
MS   analysis  of   the   same   alkaloid   extract   revealed  
  




Table 3. Viability of microorganisms after 6 hours exposure to the Sida acuta alkaloid extract.  
 
Time (h) 0 1 2 3 4 5 6 
E. coli CIP 105182 + (uc) + (uc) 20±05 05±02 - - - 
Sh. dysenteriae CIP 54051 + (uc) + (uc) + (uc) 17±04 03±02 - - 
 
                       +: for the presence of the colonies.  
                       -: for absence of colonies,.  
                     UC: uncountable.  




the presence of two major alkaloids; cryptolepine and 
quindoline. The results of the present study support the 
traditional medicinal use of S. acuta and suggest that a 
great attention should be paid to this plant which is found 
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